Lipid Signaling Flashcards
_____ is a major proinflammatory risk factor
Obesity
Instrumentation which made studying lipid immunology possible
New-generation liquid chromatography-mass spectrometry
White Adipocytes
Contain a single large lipid droplet. Cumulatively can represent ~60% of total body weight.
Adipokines
Term for hormones and signaling molecules secreted by adipose tissue. May be protein or lipid in nature.
Includes leptin, estrogen, and proinflammatory cytokines.
Obesity (specifically excessive amounts of white adipocytes) may lead continuous _______, resulting in ________.
baseline secretion of pro-inflammatory cytokines, resulting in a chronic low-grade pro-inflammatory state.
Adipose tissue macrophages (ATMs)
At the center of adipose tissue-derived inflammation.
May orchestrate secretion of pro- or anti-inflammatory cytokines depending on level of adiposity and phenotype (M1 vs M2).
Lipolysis or short-term low-calorie diets in humans leads to accumulation of ______ in adipose tissue, while obesity/excessive white fat leads to accumulation of _____ in adipose tissue.
Lipolysis or short-term low-calorie diets in humans leads to accumulation of M2 anti-infammatory macrophages in adipose tissue, while obesity/excessive white fat leads to accumulation of M1 pro-inflammatory macrophages in adipose tissue.
ATMs produce many immunoactive lipids, including . . .
prostaglandins, leukotrienes, and mono- and di-hydroxy unsaturated fatty acids
White adipocytes express many enzymes involved in the synthesis of immunoactive lipids, such as . . .
COX-1 and -2, PDG synthase, Thromboxane synthase (for generating prostaglandins and thromboxanes)
5-Lipoxygenase and Leukotriene C4 synthase (for generating leukotrienes and lipoxins)
Classical circulating lipid risk factors for inflammatory disease
Cholesteryl esters and low-density lipoprotien.
Particularly effective as risk factors for atherosclerosis and prediction of secondary vascular events.
EPA, DPA, and DPH
Omega-3 fatty acids that may be metabolized into pro-resolving lipid mediators, including resolvins and protectins.
Pro-resolving lipid mediators
Protectins
Resolvins
Maresins
Lipoxins
Maresin 1 (MaR1)
Potent pro-resolving and tissue-regenerating lipid.
Biosynthesized by MΦ, with 12-LOX as an initiating enzyme.
Inhibition of COX-2 _____ resolution.
Inhibition of COX-2 delays resolution:
Prostaglandins, despite being pro-inflammatory in most tissues, are also pro-resolution. They are initiators of lipid mediator class-switching.
Aspirin-mediated acetylation of COX-2 . . .
blocks the synthesis of prostaglandins by selectively excluding the aracadonic acid metabolite 15R-HETE from the active site. However, the EPA and DPA metabolites 18R-HEPE and 17R-HDHA are not excluded. This blocks proinfammatory PG production while allowing lipoxin, resolvin, and protectin biosynthesis.
Autocoid
Locally acting substances that are rapidly biosynthesized in response to specific stimuli, act quickly, and are usually deactivated by metabolism.
COX-1
Generally thought of as a homeostatic, housekeeping gene. Adds an epoxide group to arachadonic acid and other lipid metabolites.
COX-2
Inducible cyclo-oxygenase with roles in inflammation, pain, fever, pain transduction, mitogenesis, vascular hemodynamics, etc.
May be induced by LPS, TNF-α, IL-1, IL-2, EGF, and IFN-γ. Inhibited by endogenous glucocorticoids, IL-1β, IL-4, IL-10, IL-13, NSAIDs, and other direct COX-2 inhibiting small molecules like Rofecoxib/Viox.
Zileutron
Iron chelator which inhibits 5-LOX by cofactor sequestration.
Arachadonic Acid Cascade outline
Prostaglandin and Thromboxane Metabolism
Leukotriene Metabolism
Lipoxin Metabolism
Platelet Activating Factor Metabolism
Lipid Signaling Overview
5-Lipoxygenase
Lipoxygenase enzyme which controls production of leukotrienes.
Utilizes iron as a cofactor. Inhibited by Zileutron.
15-Lipoxygenase
Controls production of 15-S-HETE, and thereby lipoxins.
Inducible expressed in neutrophils.
Role of cytochrome p450 epoxygenases
In cells which do not express cyclooxygenases or lipoxygenases, such as kidney cells, the cytochrome p450 enzymes are the major source of immunoactive lipids (primarily epoxyeicosatrtraenoic acids).
Inactivation of prostaglandins, leukotrienes, thromboxanes, and lipoxins
These bioactive lipids are inactivated locally by hydroxylation, beta-oxidation, or omega-oxidation. This renders the lipids hydrophilic, and they are quickly delivered to the kidneys and excreted in urine.
Lipocortins
Endogenous inhibitors of phospholipase A2, the enzyme which cleaves arachadonic acid from its membrane phospholipid.
Induced by glucocorticoid signaling, which partially accounts for the immunoinhibitory effects of glucocorticoids.
Annexins
Act at GPCRs on leukocytes to block proinflammayory responses and upregulate the receptor for Lipoxin A4.
Expression is induced by glucocorticoids, providing a mechanism for glucocorticoid immunosuppression.
Phospholipase A2 (PLA2)
Family of enzymes that hydrolyze phospholipids to release fatty acids, including the precursor for arachadonic acid. Includes three isoforms:
cPLA2: A cytosolic, calcium-dependent isoform.
iPLA2: A calcium-independent isoform.
sPLA2: A secreted form.